NGAL and AKI (Acute Kidney Injury)

NGAL and AKI (Acute Kidney Injury)

A fast-responding biomarker for AKI, NGAL monomers are secreted in high levels into blood and urine upon injury of the kidney (within 2 hours or less).

Read More

NGAL in Cancer Research

NGAL in Cancer Research

NGAL is expressed in a number of solid tumours, and is the subject of research into its potential as a prognostic and diagnostic biomarker in cancer.

Read More

NGAL in Drug Development

NGAL in Drug Development

NGAL a sensitive and rapidly responding biomarker of acute kidney injury (AKI). This means that it is able to quickly detect nephrotoxicity caused by candidate compounds.

Read More

NGAL in Inflammatory Disease Research

NGAL in Inflammatory Disease Research

NGAL levels are elevated in a number of inflammatory disease conditions, and the role of NGAL in their pathophysiology is of active interest.

Read More


NGAL Products

  • NGAL Rapid ELISA
    CE IVD
  • Human NGAL ELISA
    for Research
  • Animal NGAL ELISAs
    for Research
  • NGAL-Monomer-Recombinant-Human-187x95NGAL (Monomer) Recombinant
  • Monoclonal Anti-NGAL
    antibodies